UPDATED Jan 02, 2026
Explore the Canadian (TSX) Biggest Losers Today. These Pharmaceuticals & Biotech Stocks have seen the largest drop in Market Cap from the previous trading day.
| Company | Last Price | 1D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
MDMA | CA$0.10 | -4.5% | -64.4% | CA$12.0m | n/a | PS15.2x | n/a | n/a | ||
PHRM | CA$0.10 | -4.8% | -53.5% | CA$9.6m | n/a | PB11.6x | n/a | n/a | ||
APS | CA$2.02 | -4.7% | -80.2% | CA$5.4m | CA$2.41 | PE-0.2x | n/a | n/a | ||
DCNN.X | CA$0.025 | -16.7% | n/a | CA$691.7k | n/a | PE-0.9x | n/a | n/a | ||
CPTR | CA$0.24 | -12.7% | n/a | CA$836.9k | n/a | PB0.06x | n/a | n/a | ||
TMED | CA$0.065 | -7.1% | -56.7% | CA$755.1k | n/a | PE-0.2x | n/a | n/a | ||
CHGX | CA$0.005 | 0% | -75.0% | CA$415.6k | n/a | PE-0.3x | n/a | n/a | ||
MESC | CA$0.01 | 0% | -75.0% | CA$858.6k | n/a | PB0.6x | n/a | n/a | ||
BIO | CA$0.005 | 0% | -50.0% | CA$562.1k | n/a | PE-0.3x | n/a | n/a | ||
XBRA | CA$0.005 | 0% | -87.5% | CA$420.7k | n/a | n/a | n/a | n/a | ||
MRVL | CA$0.14 | 0% | -18.2% | CA$7.8m | n/a | PE-3.4x | n/a | n/a | ||
OPTI | CA$0.32 | 0% | 50.0% | CA$30.4m | n/a | PS55.5x | n/a | n/a | ||
APLI | CA$0.025 | 0% | -28.6% | CA$3.2m | n/a | PS16.1x | n/a | n/a | ||
WIB | CA$0.13 | 0% | 4.0% | CA$2.0m | n/a | PB0.7x | n/a | n/a | ||
MJ | CA$0.02 | 0% | 33.3% | CA$702.8k | n/a | PE-0.9x | n/a | n/a | ||
NTLX | CA$0.17 | 0% | n/a | CA$14.3m | n/a | n/a | n/a | n/a | ||
KNE | CA$0.04 | 0% | -63.6% | CA$7.3m | n/a | PS12.6x | n/a | n/a | ||
RKV | CA$0.10 | 0% | -94.4% | CA$2.1m | CA$4.00 | PB1.1x | E16.9% | n/a | ||
TTI | CA$0.65 | 0% | 8.3% | CA$33.7m | n/a | PB15.6x | n/a | n/a | ||
JOLT | CA$0.085 | 0% | -15.0% | CA$1.1m | n/a | PE-1.1x | n/a | n/a | ||
PSYG | CA$0.12 | 0% | -46.7% | CA$1.9m | n/a | PB2.2x | n/a | n/a | ||
RWB | CA$0.035 | 0% | -22.2% | CA$16.5m | n/a | PE-0.4x | n/a | n/a | ||
TELO | CA$0.05 | 0% | -60.0% | CA$5.0m | n/a | PE-1.9x | n/a | n/a | ||
FNT.U | US$0.05 | 0% | -44.4% | US$31.9m | n/a | PE-0.6x | n/a | n/a |